Results 71 to 80 of about 1,552 (162)

Novel therapeutic perspectives for sarcoglycanopathy by assisting protein folding

open access: yes, 2016
Sarcoglycanopathy, the collective name of four forms of Limb Girdle Muscular Dystrophy (LGMD 2C-2F), is a rare genetic disorder affecting mainly the proximal musculature.
Elisa Bianchini   +5 more
core  

Derangement of ATP- and NAD+- related pathways in α-sarcoglycanopathy: identification of new therapeutic strategies

open access: yes
Sarcoglycanopathies, limb-girdle muscular dystrophies (LGMD), are rare genetic disorders caused by loss-of-function mutations of the membrane proteins sarcoglycans (SGs).
ASTIGIANO, CECILIA
core   +1 more source

The novel use of the CFTR corrector C17 in muscular dystrophy: pharmacological profile and in vivo efficacy [PDF]

open access: yes
Sarcoglycanopathies are rare forms of severe muscular dystrophies currently without a therapy. Mutations in sarcoglycan (SG) genes cause the reduction or absence of the SG-complex, a tetramer located in the sarcolemma that plays a protective role during ...
Benetollo, Alberto   +13 more
core   +1 more source

Novel zebrafish models for sarcoglycanopathy

open access: yes, 2019
Giovanni Risato   +7 more
core   +2 more sources

LGMD2E patients risk developing dilated cardiomyopathy

open access: yes, 2003
Sarcoglycan gene mutations cause various limb-girdle muscular dystrophies. The sarcoglycans are expressed both in skeletal and cardiac muscle but, surprisingly, so far only a few sarcoglycanopathy patients have had documented cardiomyopathy.
MELACINI, PAOLA   +4 more
core  

Rescue of folding-defective alpha-sarcoglycan mutants by means of protein folding correctors

open access: yes, 2016
Sarcoglycans (SG) are glycosylated proteins (alpha-, beta-, delta- or gamma-SG) forming a key structural complex, essential for the sarcolemma integrity of striated muscles during contraction.
Elisa Bianchini   +5 more
core  

Sarcoglycanopathies, therapeutic approaches based on small molecules

open access: yes, 2018
Sarcoglycanopathies are rare autosomal recessive diseases affecting striated muscle, sharing a similar phenotype. The pathology is due to defects in four genes, SGCA, SGCB, SGCD and SGCG coding for α-, β-, δ- and γ-sarcoglycan (SG), respectively.
Elisa Bianchini   +5 more
core  

Sarcoglycanopathies diagnosed at neurology department of Centro Hospitalar e Universitário de Coimbra

open access: yes, 2013
Trabalho final de mestrado integrado em Medicina área científica de Neurologia-Doenças Neuro-Musculares, apresentado á Faculdade de Medicina da Universidade de CoimbraIntroduction: Sarcoglycanopathies are muscle dystrophies with autossomic recessive ...
Lopes, Sara Daniela Braga Brandão
core  

Home - About - Disclaimer - Privacy